Regen BioPharma Inc (RGBP)

[OTCShotCaller]

Pink Current = North of $1.00 EASILY WITHIN WEEKS!!!

WHY?

I'll again use a comparative analogy of ENZC Vs. RGBP (both Biophama development companies)

ENZC
(History)

Nov 2, 2020
PPS .0132
Not Pink Current but proactively moving in that direction
(1) Patent
No Licensing of Patent
No Partnerships
No Revenue
PPS began to rise Late Nov to early Dec 2020 in anticipation of going Pink Current.

On Nov 24th the PPS hit 0.04; a 67% increase from Nov 2nd. Then on
on Dec 1st 2020 the PPS went to 0.11; an additional 175% increase.

MOVING FORWARD
January 13, 2021
ENZC went Pink Current
PPS 0.125
No Licensing of Patent
No Partnerships
No Revenue

On Jan 27th 2021 the PPS more than doubled to 0.2650based solely on going Pink Current plus nothing else whatsoever. At this point there was a 1,907% increase in the PPS relative to Nov 2, 2020.

Moving forward on 2/9/2021 ENZC hit 0.958; a 666.4% increase in only 19 trading days AFTER going Pink Current!

AGAIN WHY?

Pink Current immediately results in broad access to multiple trading platforms, plain & simple.

* * * CONTRAST * * *

RGBP
June 11, 2021
PPS 0.0198
Not Pink Current but proactively moving in that direction
Presently reviving several of its 22 Patents (see 5/7/21 8K)
Has licensed (2) of its Active Patents:

#1- On April 7, 2021 Regen Biopharma, Inc, entered into an agreement with Oncology Pharma, Inc. whereby Regen granted an exclusive right and license for the development and commercialization of its Patent for treatment of pancreatic cancer. This Patent will be used to produce an antigen specific cancer vaccine in which modified mRNA will be administered to patients to confer immunity.

#2- On April 7, 2021 KCL Therapeutics, Inc.; a wholly owned subsidiary of Regen Biopharma, entered into an agreement with Oncology Pharma, Inc. whereby KCL granted an exclusive right and license for the development and commercialization of its Patent for the treatment of colon cancer.

As a result of these two licensing arrangements RGBP has already received up front payment in cash & stock from Oncology Pharma, and is guaranteed royalty payments for 15 Years for 10% of all proceeds generated from Licensing, and 5% for Sub-Licensing to 3rd Party Pharmaceutical Companies.

Oncology Pharma (ONPH) last traded at $31.81 this past Friday 6/11/21 and has a 52 Week High of $50. On its website, it lists RGBP as a "potential partner" in the space of Oncology Therapeutics.

https://www.oncology-pharma.com/news

Now based on these FACTS I believe it would be a reasonable assumption that with the anticipation setting in for RGBP going Pink Current within weeks from now (like what happened to ENZC), its PPS should be expected to rise in the same manner, if not MUCH HIGHER, than ENZC's run to 0.95, and this would be based on RBGP having Licensed TWO (2) PATENTS soon going into pharmaceutical production in the colon & pancreatic cancer treatment space utilizing the disruptive biotechnology of an mRNA Vaccine that at some point will undoubtedly go global..

It's time to start using some common sense here!

RGBP GOING PINK CURRENT IS THE NAME OF THAT TUNE IN AND OF ITSELF ALL BY ITSELF!

Then when its mRNA Vaccine Technology goes into mass production for global distribution there will undoubtedly be an EXPLOSION in its PPS to unimaginable heights, and YET there are several more of RGBP's Patents presently being revived with the prospect of licensing.

In closing, everyone in this play knows that Koos MUST get Pink Current BEFORE the SEC deadline September 28, 2021, and that all disclosures "should" be provided to the SEC by June 30, 2021. It was made very clear in recent PRs that he has hired a top drawer professional auditor to accomplish this by the deadline.

https://www.otcmarkets.com/corporate-services/information-for-pink-companies

Then on top of this he recently filed an 8K on 4/23/21 that protects RGBP from a Hostile Take Over in the event of a Buy Out, where any potential bidders are required to negotiate directly with himself being in full control of the Board due to is majority share position.Therefore the specter of a Buy Out by a Big Pharma might come in the wake of going Pink Current which is a real possibility.

https://www.otcmarkets.com/filing/html?id=14894907&guid=ezRnUpxpMbxhQth

With all of this in mind I fully anticipate RGBP's PPS to begin a steady and consistent rise this coming week 6/14/21 moving forward based on this SEC Mandate combined with ALL the above!

IMO, PPS well above $1 by Fall 2021 (if not sooner) which I believe is by FAR a reasonable assumption based on the provided comparative analogy presented in this post.

Bottom line is ENZC's Market position was no where near RGBP's current position when it made it's run to 0.95, not close by a long shot!

What was the fundamental and sole cause of this happening?? IT WENT PINK CURRENT instantly opening the door WIDE for trading on multiple platforms and within 19 trading days of that happening it hit nearly $1.00!!

I rest my case....all feedback welcome.

Be well and prosper...